Table 1 Patient demographics
Patient with post-IVTA endophthalmitisAgeIndicationCulture resultsPhakic statusCapsule statusPre-IVTA injection visual acuityPresenting visual acuityVisual acuity, 1 monthMonth
162RVONegativePseudophakicIntact20/100HM20/80May 2005
276RVONegativePhakicNA20/80HM20/60Jan 2006
373RVONegativePhakicNA20/100CF20/50May 2006
467DMENegativePseudophakicIntactCFHM20/400May 2006
565DMENegativePhakicNA20/200CF20/150May 2006
676RVONegativePseudophakicRuptured20/60HM20/100June 2006
769CMENegativePseudophakicIntact20/50HM20/70June 2006
885CMENegativePseudophakicIntact20/150HM20/50July 2006
981DMENegativePseudophakicIntact20/60HM20/60July 2006
1067CMENegativePseudophakicIntact20/70HM20/70July 2006
1185DMENegativePhakicNA20/150HM20/60July 2006
  • CF, count fingers; CME, cystoid macular oedema secondary to pseudophakia; DME, diabetic macular oedema; HM, hand motion; IVTA, intravitreal injection of triamcinolone acetonide; NA, not applicable; RVO, retinal vein occlusion.